Digital health app for fatty liver disease
Part of Digestive system, Hormones & metabolism clinical trials.
This trial tests a digital health app designed to help people with metabolic-associated fatty liver disease (MAFLD). The app provides diet and exercise guidance to improve liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a body mass index (BMI) between 24 and 35.
- You have been diagnosed with fatty liver disease related to metabolism (MAFLD) based on a FibroScan or MRI test.
- You have a smartphone that can run the study app.
- If you have type 2 diabetes, your medications have been stable for at least 3 months.
- You are not a heavy drinker (more than 3 drinks a day for men, 2 for women) within the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a digital app to help people with fatty liver disease (MASLD) manage their condition. It's for adults who are comfortable using a smartphone or have someone to help them.
This trial tests whether a digital diet and exercise program can reduce liver scarring in people with MASLD (fatty liver disease not caused by alcohol). You would use an app on your smartphone to follow the program at home.
This trial uses digital twin technology to better detect, treat, and monitor metabolic fatty liver disease (MAFLD) and its complications like heart disease and cirrhosis. It may help create more personalized care plans.
This research studies fatty liver disease linked to metabolic problems like diabetes and obesity. You'll wear a fitness tracker and have liver imaging to help doctors understand the disease and find new treatments.
This trial tests a smartphone app that sends you text messages and coaching to help you eat better, be more active, and control your blood sugar. It is for people with diabetes or prediabetes who also have signs of fatty liver disease.
This trial is testing a new ultrasound method to measure fat in the liver for people with metabolic fatty liver disease (MAFLD). It may help understand how well ultrasound can show liver fat compared to a liver biopsy or MRI.
Hear when a new MAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.